After a dry spell for cancer immunotherapy, a new target offers a beacon of hope
Oncologists may soon have a new immuno-oncology target in their arsenal. Experts expect the Food and Drug Administration to soon approve relatlimab, a
Oncologists may soon have a new immuno-oncology target in their arsenal. Experts expect the Food and Drug Administration to soon approve relatlimab, a
Easily a decade can pass before someone with a complex chronic condition gets a proper diagnosis. New telehealth companies aim to shorten that time and…
Donald Trump’s health care priorities remain fuzzy. But one thing is certain: A second Trump administration would put its own stamp on a host of…
The Joint Commission and the National Committee for Quality Assurance will launch updated accreditation programs for telehealth providers.
Gene therapies represent an evidence problem. Because they are just beginning to be used, little long-term data exists on their effectiveness and downstream risks.
In a scientific first, researchers have used CRISPR base editing to treat liver disease in fetal monkeys.
HHS released a final rule that would put abortion services under the same federal privacy protections as other health care data covered by HIPAA.
Confusion over Makena, a controversial failed preterm delivery drug, caused some pregnant women to receive an untested treatment.
The USDA order mandating H5N1 bird flu testing in dairy cows is less stringent than initially described by the agency.
Of 100 hospitals across 50 states surveyed by STAT about changes in maternal care after overturning of Roe v. Wade, only six agreed to speak.
Join STAT’s leading DC bureau as they take the stage with policymakers, patient advocates, and industry experts to discuss the biggest issues in health policy…